CNVI — Conavi Medical Cashflow Statement
0.000.00%
Last trade - 00:00- CA$34.54m
- CA$23.25m
- CA$9.12m
Annual cashflow statement for Conavi Medical, fiscal year end - September 30th, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | fx Final | Final |
| Net Income/Starting Line | -32.4 | -18.6 | -55.4 | 9.38 | -20.5 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 37.6 | -15.2 | 2.56 | 1.65 | -2.21 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -6.59 | -13 | 15.9 | -4.97 | -3.19 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.13 | -45.9 | -35.9 | 6.32 | -25.1 |
| Capital Expenditures | -0.804 | -0.946 | -1.33 | -0.287 | -0.183 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | — | — | 0.32 | 3.75 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.804 | -0.946 | -1.33 | 0.032 | 3.57 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 35 | 55.4 | -0.545 | -0.609 | 26.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 33.1 | 8.57 | -37.8 | 5.74 | 5.41 |